Jazz Pharmaceuticals (JAZZ) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $130.4 million.
- Jazz Pharmaceuticals' Other Gross PP&E Adjustments rose 3873.97% to $130.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.4 million, marking a year-over-year increase of 3873.97%. This contributed to the annual value of $255.6 million for FY2024, which is 3503.92% up from last year.
- According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Other Gross PP&E Adjustments is $130.4 million, which was up 3873.97% from -$52.1 million recorded in Q2 2025.
- Over the past 5 years, Jazz Pharmaceuticals' Other Gross PP&E Adjustments peaked at $255.6 million during Q4 2024, and registered a low of -$221.1 million during Q1 2024.
- In the last 5 years, Jazz Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$27.4 million in 2022 and averaged $15.2 million.
- As far as peak fluctuations go, Jazz Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 152275.01% in 2021, and later plummeted by 14499.51% in 2024.
- Jazz Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $218.3 million in 2021, then rose by 0.57% to $219.6 million in 2022, then fell by 13.81% to $189.3 million in 2023, then soared by 35.04% to $255.6 million in 2024, then tumbled by 48.99% to $130.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at $130.4 million for Q3 2025, versus -$52.1 million for Q2 2025 and -$174.0 million for Q1 2025.